Follow the people · Insider
John W. Childs
John W. Childs files insider transactions with the SEC as a director of Veradermics (MANE). We hold 4 disclosed purchases and sales filed since 26 November 2010, 1 of them in the last 90 days.
- Files forMANE
- Disclosed buys and sells4 in all, 1 in the last 90 days
- Last disclosure14 August 2026
Positions held
5 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 February 2026 — 12 August 2026Director · Veradermics (MANE)21 Form 4 lines · source: SEC Form 4
- Filed 9 May 2017 — 28 April 2026Director · Biohaven Pharmaceutical Holding Co (BHVN)89 Form 4 lines · source: SEC Form 4
- Filed 19 December 2013 — 13 April 2015Director and 10% owner · Mattress Firm Holding (MFRM)11 Form 4 lines · source: SEC Form 4
- Filed 25 June 2012 — 21 August 2012Chairman & CEO · JWC Acquisition (JWCA)6 Form 4 lines · source: SEC Form 4
- Filed 3 February 2010 — 5 May 2011Chairman & CEO · JWC Acquisition (NONE)18 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 15,000 shares of VeradermicsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 80,000 shares of VeradermicsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- ▼ sold on the open market 5,000 shares of VeradermicsSEC Form 414 August 2026Common Stock · traded 12 August 2026 · filed 14 August 2026
- was granted 68,693 shares of Biohaven (a derivative holding)SEC Form 430 April 2026Stock Options (Right to buy) · traded 28 April 2026 · filed 30 April 2026
- ▲ bought on the open market 28,400 shares of BiohavenSEC Form 49 March 2026Common Shares · traded 4 March 2025 · filed 9 March 2026
- ▲ bought on the open market 28,400 shares of BiohavenSEC Form 49 March 2026Common Shares · traded 4 March 2025 · filed 9 March 2026
- ▲ bought on the open market 294,117 shares of VeradermicsSEC Form 427 February 2026Common Stock · traded 5 February 2026 · filed 27 February 2026
- ▲ bought on the open market 294,117 shares of VeradermicsSEC Form 427 February 2026Common Stock · traded 5 February 2026 · filed 27 February 2026
- converted 480,269 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
- converted 906,862 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
- converted 520,758 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
- converted 480,269 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Series A Convertible Preferred Stock · traded 5 February 2026 · filed 5 February 2026
- converted 906,862 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Series B Convertible Preferred Stock · traded 5 February 2026 · filed 5 February 2026
- converted 520,758 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Series C Convertible Preferred Stock · traded 5 February 2026 · filed 5 February 2026
- was granted 51,525 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Stock Option (Right to Buy) · traded 3 February 2026 · filed 5 February 2026
- ▲ bought on the open market 294,117 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
- converted 480,269 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Series A Convertible Preferred Stock · traded 5 February 2026 · filed 5 February 2026
- converted 906,862 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Series B Convertible Preferred Stock · traded 5 February 2026 · filed 5 February 2026
- converted 520,758 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Series C Convertible Preferred Stock · traded 5 February 2026 · filed 5 February 2026
- was granted 51,525 shares of Veradermics (a derivative holding)SEC Form 45 February 2026Stock Option (Right to Buy) · traded 3 February 2026 · filed 5 February 2026
- converted 480,269 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
- converted 906,862 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
- converted 520,758 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
- ▲ bought on the open market 294,117 shares of VeradermicsSEC Form 45 February 2026Common Stock · traded 5 February 2026 · filed 5 February 2026
- ▲ bought on the open market 3,333,333 shares of BiohavenSEC Form 417 November 2025Common Shares · traded 13 November 2025 · filed 17 November 2025
- was granted 31,716 shares of Biohaven (a derivative holding)SEC Form 47 May 2025Stock Options (Right to buy) · traded 5 May 2025 · filed 7 May 2025
- ▲ bought on the open market 73,170 shares of BiohavenSEC Form 45 March 2025Common Shares · traded 22 April 2024 · filed 5 March 2025
- ▲ bought on the open market 25,000 shares of BiohavenSEC Form 45 March 2025Common Shares · traded 4 March 2025 · filed 5 March 2025
- ▲ bought on the open market 3,400 shares of BiohavenSEC Form 45 March 2025Common Shares · traded 4 March 2025 · filed 5 March 2025
- ▲ bought on the open market 3,400 shares of BiohavenSEC Form 45 March 2025Common Shares · traded 4 March 2025 · filed 5 March 2025
- ▲ bought on the open market 900 shares of BiohavenSEC Form 45 March 2025Common Shares · traded 4 March 2025 · filed 5 March 2025
- ▲ bought on the open market 29,000 shares of BiohavenSEC Form 431 December 2024Common Shares · traded 30 December 2024 · filed 31 December 2024
- ▲ bought on the open market 21,052 shares of BiohavenSEC Form 43 October 2024Common Shares · traded 2 October 2024 · filed 3 October 2024
- ▲ bought on the open market 28,400 shares of BiohavenSEC Form 419 July 2024Common Shares · traded 18 July 2024 · filed 19 July 2024
- ▲ bought on the open market 28,000 shares of BiohavenSEC Form 431 May 2024Common Shares · traded 30 May 2024 · filed 31 May 2024
- ▲ bought on the open market 28,500 shares of BiohavenSEC Form 414 May 2024Common Shares · traded 13 May 2024 · filed 14 May 2024
- was granted 16,592 shares of Biohaven (a derivative holding)SEC Form 42 May 2024Stock Option (Right to Buy) · traded 30 April 2024 · filed 2 May 2024
- ▲ bought on the open market 24,391 shares of BiohavenSEC Form 423 April 2024Common Shares · traded 22 April 2024 · filed 23 April 2024
- ▲ bought on the open market 97,560 shares of BiohavenSEC Form 423 April 2024Common Shares · traded 22 April 2024 · filed 23 April 2024
- ▲ bought on the open market 73,170 shares of BiohavenSEC Form 423 April 2024Common Shares · traded 22 April 2024 · filed 23 April 2024
- was granted 2,091 shares of BiohavenSEC Form 45 April 2024Common Shares · traded 5 April 2024 · filed 5 April 2024
- was granted 19,412 shares of BiohavenSEC Form 48 March 2024Common Shares · traded 8 March 2024 · filed 8 March 2024
- acquired or disposed of, other 48,505 shares of BiohavenSEC Form 410 January 2024Common Shares · traded 8 January 2024 · filed 10 January 2024
- ▲ bought on the open market 318,000 shares of BiohavenSEC Form 410 October 2023Common Shares · traded 5 October 2023 · filed 10 October 2023
- ▲ bought on the open market 136,545 shares of BiohavenSEC Form 410 October 2023Common Shares · traded 5 October 2023 · filed 10 October 2023
- ▲ bought on the open market 50,000 shares of BiohavenSEC Form 431 August 2023Common Shares · traded 30 August 2023 · filed 31 August 2023
- ▲ bought on the open market 100,000 shares of BiohavenSEC Form 47 August 2023Common Shares · traded 4 August 2023 · filed 7 August 2023
- was granted 52,906 shares of Biohaven (a derivative holding)SEC Form 44 May 2023Stock Option (Right to Buy) · traded 2 May 2023 · filed 4 May 2023
- ▲ bought on the open market 2,380,952 shares of BiohavenSEC Form 422 March 2023Common Shares · traded 25 October 2022 · filed 22 March 2023
- ▲ bought on the open market 1,328,867 shares of BiohavenSEC Form 422 March 2023Common Shares · traded 25 October 2022 · filed 22 March 2023
- ▲ bought on the open market 3,900,000 shares of BiohavenSEC Form 426 October 2022Common Shares · traded 25 October 2022 · filed 26 October 2022
- acquired or disposed of, other 4,119 shares of Biohaven (a derivative holding)SEC Form 45 October 2022Stock Options (Right to Buy) · traded 3 October 2022 · filed 5 October 2022
- acquired or disposed of, other 5,998 shares of Biohaven (a derivative holding)SEC Form 45 October 2022Stock Options (Right to Buy) · traded 3 October 2022 · filed 5 October 2022
- exercised options over 4,119 shares of Biohaven (a derivative holding)SEC Form 45 October 2022Stock Options (Right to Buy) · traded 3 October 2022 · filed 5 October 2022
- exercised options over 5,998 shares of Biohaven (a derivative holding)SEC Form 45 October 2022Stock Options (Right to Buy) · traded 3 October 2022 · filed 5 October 2022
- was granted 125,000 shares of Biohaven (a derivative holding)SEC Form 45 October 2022Stock Options (Right to Buy) · traded 3 October 2022 · filed 5 October 2022
- acquired or disposed of, other 1,517,500 shares of BiohavenSEC Form 45 October 2022Common Shares · traded 3 October 2022 · filed 5 October 2022
- exercised options over 4,119 shares of BiohavenSEC Form 45 October 2022Common Shares · traded 3 October 2022 · filed 5 October 2022
- exercised options over 5,998 shares of BiohavenSEC Form 45 October 2022Common Shares · traded 3 October 2022 · filed 5 October 2022
- had shares withheld for tax on 5,507 shares of BiohavenSEC Form 45 October 2022Common Shares · traded 3 October 2022 · filed 5 October 2022
- acquired or disposed of, other 1,512,500 shares of BiohavenSEC Form 45 October 2022Common Shares · traded 3 October 2022 · filed 5 October 2022
- acquired or disposed of, other 5,000 shares of BiohavenSEC Form 45 October 2022Common Shares · traded 3 October 2022 · filed 5 October 2022
- ▲ bought on the open market 241,300 shares of BiohavenSEC Form 45 October 2022Common Shares · traded 5 October 2022 · filed 5 October 2022
- ▲ bought on the open market 32,841 shares of BiohavenSEC Form 45 October 2022Common Shares · traded 5 October 2022 · filed 5 October 2022
- returned to the issuer 8,239 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 43 October 2022Stock Options (Right to Buy) · traded 3 October 2022 · filed 3 October 2022
- returned to the issuer 11,996 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 43 October 2022Stock Options (Right to Buy) · traded 3 October 2022 · filed 3 October 2022
- returned to the issuer 3,025,001 shares of Biohaven Pharmaceutical Holding CoSEC Form 43 October 2022Common Shares · traded 3 October 2022 · filed 3 October 2022
- returned to the issuer 10,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 43 October 2022Common Shares · traded 3 October 2022 · filed 3 October 2022
- was granted 8,239 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 429 April 2022Stock Option (Right to Buy) · traded 28 April 2022 · filed 29 April 2022
- exercised options over 212,500 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 417 November 2021Stock Option (Right to Buy) · traded 15 November 2021 · filed 17 November 2021
- exercised options over 150,000 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 417 November 2021Stock Option (Right to Buy) · traded 15 November 2021 · filed 17 November 2021
- exercised options over 37,700 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 417 November 2021Stock Option (Right to Buy) · traded 15 November 2021 · filed 17 November 2021
- exercised options over 18,000 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 417 November 2021Stock Option (Right to Buy) · traded 15 November 2021 · filed 17 November 2021
- exercised options over 18,000 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 417 November 2021Stock Option (Right to Buy) · traded 15 November 2021 · filed 17 November 2021
- exercised options over 20,000 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 417 November 2021Stock Option (Right to Buy) · traded 15 November 2021 · filed 17 November 2021
- exercised options over 18,000 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 417 November 2021Stock Option (Right to Buy) · traded 15 November 2021 · filed 17 November 2021
- exercised options over 212,500 shares of Biohaven Pharmaceutical Holding CoSEC Form 417 November 2021Common Shares · traded 15 November 2021 · filed 17 November 2021
- exercised options over 150,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 417 November 2021Common Shares · traded 15 November 2021 · filed 17 November 2021
- exercised options over 37,700 shares of Biohaven Pharmaceutical Holding CoSEC Form 417 November 2021Common Shares · traded 15 November 2021 · filed 17 November 2021
- exercised options over 18,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 417 November 2021Common Shares · traded 15 November 2021 · filed 17 November 2021
- exercised options over 18,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 417 November 2021Common Shares · traded 15 November 2021 · filed 17 November 2021
- exercised options over 20,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 417 November 2021Common Shares · traded 15 November 2021 · filed 17 November 2021
- exercised options over 18,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 417 November 2021Common Shares · traded 15 November 2021 · filed 17 November 2021
- ▲ bought on the open market 3,890 shares of Biohaven Pharmaceutical Holding CoSEC Form 410 November 2021Common Shares · traded 10 November 2021 · filed 10 November 2021
- ▲ bought on the open market 1,110 shares of Biohaven Pharmaceutical Holding CoSEC Form 410 November 2021Common Shares · traded 10 November 2021 · filed 10 November 2021
- was granted 11,996 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 47 May 2021Stock Option (Right to Buy) · traded 5 May 2021 · filed 7 May 2021
- ▲ bought on the open market 13,157 shares of Biohaven Pharmaceutical Holding CoSEC Form 417 March 2021Common Shares · traded 17 March 2021 · filed 17 March 2021
- ▲ bought on the open market 10,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 43 March 2021Common Shares · traded 2 March 2021 · filed 3 March 2021
- acquired or disposed of, other 5,706 shares of Biohaven Pharmaceutical Holding CoSEC Form 412 February 2021Common Shares · traded 25 January 2021 · filed 12 February 2021
- ▲ bought on the open market 5,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 423 November 2020Common Shares · traded 23 November 2020 · filed 23 November 2020
- ▲ bought on the open market 3,322 shares of Biohaven Pharmaceutical Holding CoSEC Form 422 September 2020Common Shares · traded 21 September 2020 · filed 22 September 2020
- ▲ bought on the open market 6,678 shares of Biohaven Pharmaceutical Holding CoSEC Form 414 September 2020Common Shares · traded 11 September 2020 · filed 14 September 2020
- ▲ bought on the open market 2,600 shares of Biohaven Pharmaceutical Holding CoSEC Form 412 August 2020Common Shares · traded 11 August 2020 · filed 12 August 2020
- ▲ bought on the open market 7,271 shares of Biohaven Pharmaceutical Holding CoSEC Form 412 August 2020Common Shares · traded 11 August 2020 · filed 12 August 2020
- ▲ bought on the open market 15,129 shares of Biohaven Pharmaceutical Holding CoSEC Form 412 August 2020Common Shares · traded 11 August 2020 · filed 12 August 2020
- was granted 18,000 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 41 May 2020Stock Option (Right to Buy) · traded 30 April 2020 · filed 1 May 2020
- ▼ sold on the open market 144,659 shares of Biohaven Pharmaceutical Holding CoSEC Form 48 April 2020Common Shares · traded 6 April 2020 · filed 8 April 2020
- ▼ sold on the open market 5,341 shares of Biohaven Pharmaceutical Holding CoSEC Form 48 April 2020Common Shares · traded 6 April 2020 · filed 8 April 2020
- ▼ sold on the open market 81,090 shares of Biohaven Pharmaceutical Holding CoSEC Form 48 April 2020Common Shares · traded 7 April 2020 · filed 8 April 2020
- ▼ sold on the open market 10,908 shares of Biohaven Pharmaceutical Holding CoSEC Form 48 April 2020Common Shares · traded 7 April 2020 · filed 8 April 2020
- ▼ sold on the open market 93,268 shares of Biohaven Pharmaceutical Holding CoSEC Form 48 April 2020Common Shares · traded 7 April 2020 · filed 8 April 2020
- ▼ sold on the open market 14,734 shares of Biohaven Pharmaceutical Holding CoSEC Form 48 April 2020Common Shares · traded 7 April 2020 · filed 8 April 2020
- ▲ bought on the open market 10,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 426 June 2019Common Shares · traded 26 June 2019 · filed 26 June 2019
- was granted 18,000 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 423 May 2019Stock Option (Right to Buy) · traded 21 May 2019 · filed 23 May 2019
- exercised options over 107,500 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 45 April 2019Warrant to Purchase Common Shares (Right to Buy) · traded 22 March 2019 · filed 5 April 2019
- exercised options over 107,500 shares of Biohaven Pharmaceutical Holding CoSEC Form 45 April 2019Common Shares · traded 22 March 2019 · filed 5 April 2019
- was granted 18,000 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 43 May 2018Stock Option (Right to Buy) · traded 1 May 2018 · filed 3 May 2018
- converted 1,035,938 shares of Biohaven Pharmaceutical Holding CoSEC Form 49 May 2017Common Shares · traded 9 May 2017 · filed 9 May 2017
- ▲ bought on the open market 415,000 shares of Biohaven Pharmaceutical Holding CoSEC Form 49 May 2017Common Shares · traded 9 May 2017 · filed 9 May 2017
- converted 1,035,938 shares of Biohaven Pharmaceutical Holding Co (a derivative holding)SEC Form 49 May 2017Series A Preferred Shares · traded 9 May 2017 · filed 9 May 2017
- ▼ sold on the open market 1,462,468 shares of Mattress Firm HoldingSEC Form 414 April 2015Common Stock · traded 13 April 2015 · filed 14 April 2015
- ▼ sold on the open market 37,532 shares of Mattress Firm HoldingSEC Form 414 April 2015Common Stock · traded 13 April 2015 · filed 14 April 2015
- ▼ sold on the open market 288,334 shares of Mattress Firm HoldingSEC Form 415 January 2015Common Stock · traded 14 January 2015 · filed 15 January 2015
- ▼ sold on the open market 7,548 shares of Mattress Firm HoldingSEC Form 415 January 2015Common Stock · traded 14 January 2015 · filed 15 January 2015
- ▼ sold on the open market 1,914,581 shares of Mattress Firm HoldingSEC Form 418 December 2014Common Stock · traded 16 December 2014 · filed 18 December 2014
- ▼ sold on the open market 50,121 shares of Mattress Firm HoldingSEC Form 418 December 2014Common Stock · traded 16 December 2014 · filed 18 December 2014
- acquired or disposed of, other 113,610 shares of Mattress Firm HoldingSEC Form 417 April 2014Common Stock · traded 15 April 2014 · filed 17 April 2014
- acquired or disposed of, other 421,452 shares of Mattress Firm HoldingSEC Form 49 April 2014Common Stock · traded 20 December 2013 · filed 9 April 2014
- gave away 421,452 shares of Mattress Firm HoldingSEC Form 49 April 2014Common Stock · traded 31 December 2013 · filed 9 April 2014
- acquired or disposed of, other 421,452 shares of Mattress Firm HoldingSEC Form 46 January 2014Common Stock, par value $0.01 per share · traded 19 December 2013 · filed 6 January 2014
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.